Fundraising FoxPhoenixkinetics
1 known investors
Find your way into Phoenixkinetics
Sign up to see every warm intro you have to Phoenixkinetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phoenixkinetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phoenix Kinetics develops the NUsurface meniscus implant, a device that preserves knee motion and provides pain relief for patients with early knee osteoarthritis who fall between meniscal allograft transplantation and total knee replacement. The company targets an estimated U.S. patient population of over one million and has run clinical trials demonstrating pain reduction and improved physical function.
Founders & leadership
RB
Ryan BelaneyCEO
AK
Adam KlyceVP of Marketing & Communications
KH
Kirk HansonVP of Medical Education and Clinical Operations
Investors · 1
Bantam Grouplisted by Bantam GroupWestwood
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Phoenixkinetics do?
- Phoenix Kinetics develops the NUsurface meniscus implant, a device that preserves knee motion and provides pain relief for patients with early knee osteoarthritis who fall between meniscal allograft transplantation and total knee replacement. The company targets an estimated U.S. patient population of over one million and has run clinical trials demonstrating pain reduction and improved physical function.
- Who are Phoenixkinetics's investors?
- Phoenixkinetics's investors include Bantam Group.